Organization Overview
Historical Acquisition Tree
Alternative names
tocilizumab (actemra) (1997)
aflibercept (zaltrap) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
atezolizumab (Tecentriq) (5 trials)
bendamustine (treanda) (2 trials)
bevacizumab (avastin) (8 trials)
capecitabine (xeloda) (5 trials)
chlorambucil (Leukeran) (1 trial)
cisplatin (platinol) (3 trials)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
docetaxel (taxotere) (2 trials)
doxorubicin (Doxil) (3 trials)
eculizumab (Soliris) (2 trials)
emicizumab (Hemlibra) (5 trials)
faricimab (Vabysmo) (2 trials)
fluorouracil (efudex) (5 trials)
gemcitabine (gemzar) (2 trials)
gemtuzumab ozogamicin (mylotarg) (1 trial)
ibandronate (boniva) (1 trial)
irinotecan (Camptosar) (2 trials)
methoxy polyethylene glycol-epoetin beta (Mircera) (6 trials)
Adenocarcinoma (Phase 3)
Alzheimer Disease (Phase 1)
Anemia (Phase 3)
Anemia, Aplastic (Phase 3)
Aortic Arch Syndromes (Phase 3)
Arteritis (Phase 3)
Arthritis (Phase 3)
Arthritis, Juvenile (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Atherosclerosis (Phase 3)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Colorectal Neoplasms (Phase 3)
Coronary Restenosis (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Fibrosis (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastroparesis (Phase 2)
Giant Cell Arteritis (Phase 2)
Graft Occlusion, Vascular (Phase 3)
Hemoglobinuria (Phase 3)
Hemoglobinuria, Paroxysmal (Phase 3)
Hemophilia A (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 4)
Hepatitis, Chronic (Phase 4)
Hodgkin Disease (Phase 3)
Hypercalcemia (Phase 2)
Hyperphosphatemia (Phase 4)
Hypoparathyroidism (Phase 1)
Kidney Diseases (Phase 1)
Leukemia (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 3)
Liver Neoplasms (Phase 3)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoproliferative Disorders (Phase 3)
Multiple Myeloma (Phase 3)
Muscle Spasticity (Phase 4)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 1)
Neuromyelitis Optica (Phase 3)
Osteoporosis (Phase 3)
Osteosarcoma (Phase 3)
Polymyalgia Rheumatica (Phase 2)
Renal Insufficiency, Chronic (Phase 1)
Sarcoma (Phase 3)
Stomach Neoplasms (Phase 3)
Takayasu Arteritis (Phase 3)